What is Promescent?
Promescent has carved a niche in the sexual wellness market by offering a comprehensive range of products designed to improve sexual experiences. Their portfolio includes delay sprays, lubricants, condoms, dietary supplements, and intimacy devices, all developed with a focus on enhancing pleasure and prolonging intimacy. The company's commitment to efficacy is highlighted by its recommendation from over 4,000 doctors worldwide. Promescent prioritizes customer privacy through discreet packaging and offers free shipping within the United States for orders exceeding $20, demonstrating a customer-centric approach to its business model.
How much funding has Promescent raised?
Promescent has raised a total of $1.8M across 2 funding rounds:
Private Equity
$561K
Private Equity
$1.2M
Private Equity (2012): $561K, investors not publicly disclosed
Private Equity (2013): $1.2M, investors not publicly disclosed
What's next for Promescent?
The recent major strategic investment signals a pivotal phase for Promescent, likely enabling the company to scale its operations, expand its product development, and broaden its market reach. This infusion of capital is expected to fuel further innovation in sexual wellness solutions and reinforce Promescent's position as a trusted provider recommended by healthcare professionals. The company is poised to leverage this financial backing to enhance its direct-to-consumer channels and potentially explore new strategic partnerships within the health and wellness sector.
See full Promescent company page
